AMETEK’s second quarter results were met with a positive market response, driven by broad-based demand across multiple end markets, particularly in semiconductor, aerospace, and MedTech applications. Management emphasized that robust organic growth, supported by recent acquisitions and high order volumes, contributed significantly to overall performance. CEO David Zapico noted that the company’s ability to deliver “double-digit organic sales growth” and a record backlog was supported by strong execution and effective working capital management. The company’s Electronic Instruments Group benefited from process instrumentation and power solutions, while the Electromechanical Group saw notable contributions from MedTech and automation businesses.
Is now the time to buy AME? Find out in our full research report (it’s free for active Edge members).
AMETEK (AME) Q2 CY2026 Highlights:
- Revenue: $2.04 billion vs analyst estimates of $1.96 billion (15% year-on-year growth, 4.4% beat)
- Adjusted EPS: $2.09 vs analyst estimates of $1.99 (4.8% beat)
- Management raised its full-year Adjusted EPS guidance to $8.25 at the midpoint, a 2.6% increase
- Operating Margin: 25.8%, in line with the same quarter last year
- Market Capitalization: $57.98 billion
While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From AMETEK’s Q2 Earnings Call
-
Deane Dray (RBC Capital Markets) asked if AMETEK is seeing broad-based end-market strength or concentrated growth in specific sectors. CEO David Zapico explained that while AI and semiconductor infrastructure are major contributors, growth is diversified across process, aerospace, and power markets.
-
Matt Summerville (D.A. Davidson) inquired about backlog quality and shipment timing. Zapico noted that approximately 80% of backlog is expected to ship within 12 months and emphasized improved execution and visibility.
-
Nicole DeBlase (Deutsche Bank) questioned the sustainability of recent order growth and whether there was conservatism in the guidance. Zapico responded that organic growth guidance reflects both strong recent orders and prudent forecasting.
-
Daniel DiCicco (BMO Capital Markets) asked about which markets outperformed and if internal AI initiatives are yielding productivity gains. Zapico identified semiconductor and MedTech as standouts and described ongoing AI-driven efficiency projects across the company.
-
Scott Graham (Seaport Research Partners) probed the drivers of core margin expansion. Zapico attributed margin improvement to Paragon Medical’s integration, operational productivity, and positive pricing dynamics.
Catalysts in Upcoming Quarters
In upcoming quarters, our analysts will monitor (1) the pace of order conversion to revenue and any shifts in backlog realization, (2) the successful integration and margin contribution from acquisitions including Indicor and FARO, and (3) continued demand strength in end markets such as AI-driven semiconductors, aerospace, and MedTech. Execution on product innovation and productivity targets will also be closely watched.
AMETEK currently trades at $257, up from $243.77 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.